All rights reserved. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. Strong Competition: Surely, Zomedica would have plans to expand its product offerings over the next few years. Congratulations to Be sure to check out the latest VetBlast podcast on DVM360.com. Lets take a closer look to see if this is a penny stock play. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) PRESS RELEASE Accesswire Aug. 13 . But does the prospect of finally generating revenue justify a 2,500% surge in ZOM stock price in four months? Zomedica Corp (NYSE:ZOM) has been an interesting case study in the power of hype Reddit, Robinhood and celebrity endorsements (even accidental ones) to propel a stock to stratospheric levels. Six months ago, 15 million shares would trade hands on a good day. Zomedica is facing an uphill task of making a dent in a market that has some gorillas. However, you may visit "Cookie Settings" to provide a controlled consent. You may find his writing a little different than other stock articles youve read. About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. In-depth profiles and analysis for 20,000 public companies. We dedicate ourselves to serving the needs of the broader veterinary community by offering lab services through Bloodhound laboratories, which will allow our practice partners to also advance their endocrine practice. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. This assay will enable quantification of samples with low levels of TSH, which is necessary to discriminate normal and hyperthyroid feline samples. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Combined with the previously verified canine total tT4 assay, the total represents the completion of the first two assays for both canine and feline of the total of five assays initially planned for use with the TRUFORMA platform. And at a time when pet ownership in the U.S. has never been higher, thanks to the pandemic. And if the company has to wait for some revenue, its best to have some cash on hand. 0.0001). 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, Proterra Inc., A Penny Stock To Put On The Watchlist, Buffett Reduces Taiwan Semiconductor Stake After This Happened, Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI, Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, Why Restaurant Stocks are the Stocks to Buy Right Now, View 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, View Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, View Proterra Inc., A Penny Stock To Put On The Watchlist, View 3 Healthcare Stocks Insiders Are Buying, View Buffett Reduces Taiwan Semiconductor Stake After This Happened, View Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI. THIS IS SIGNIFICANT and could result in a very quick ROI for the vet offices. And one of the concerns about Truforma is that Truforma relies on licensed technology. Zomedica Appoints New Chief Financial Officer, Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity Revenue up 361% from 2021 through combination of acquisitions and organic growth, Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15, Zomedica Corp. Diagnostics Initiation Report, Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022, Zomedica to Participate in the Lytham Partners Investor Select Conference, Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies, Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors, Zomedica to Present at Sidoti Virtual Investor Conference January 18-19, Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans. Yes, the prospects of Truforma are truly eye-popping. The optimism about Truforma based on the growth forecasts for pet diagnostics then seems excessive. Having a point-of-care cortisol test available also was welcomed by Audrey Cook, BVM&S, Dip ACVIM at Texas A&M College of Veterinary Medicine and Biomedical Sciences: Veterinarians rely on serum cortisol measurements to diagnose and manage adrenal diseases in dogs. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. Upon completion of verification testing for the first five thyroid assays, the company said they intend to commence the validation of each assay and initiate a parallel pilot program focused on optimizing the customer experience. A highly respected board-certified veterinary internist and neurologist, Dr. Bergs dedication to advancing the field of veterinary medicine has garnered national and international recognition. Our daily ratings and market update email newsletter. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding the public offering. Being able to conduct the test themselves gives faster results, allowing for a quicker start of treatment. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information. All rights reserved. Readers are cautioned that this list of risk factors should not be construed as exhaustive. Tarform. The technology is a high-precision solution presently being used to deliver cleaner signals in communications materials particularly the next-gen 5G-enabled devices. The ONLY free-T4 (fT4) assay available at point of care, eliminating inaccurate results due to sample heating during shipment to a reference laboratory. We also use third-party cookies that help us analyze and understand how you use this website. The verification studies demonstrated a dynamic range allowing the quantification of both high and low TSH concentrations within the same assay for both species, which Zomedica believes is vital for accurate diagnosis of thyroid disease in canines and felines. Concerns about Truformas addressable market: Some commentators, including InvestorPlaces Ian Cooper, point at the diagnostic market forecast as one of the reasons to be bullish about ZOM. The big news for Zomedica and any investors who have interest in this company as a long-term holding is Truforma. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. We cannot guarantee future results, performance or achievements. In January, Carole Baskin of Tiger King fame was paid $299 by a fan to mention Zomedia on Cameo. Its definitely worth checking back in to see how the company is doing once Truforma has hit the market, but for now its stock is just too volatile for my taste. Year to date, ZOM stock is up 793%. The fallouts from that hype have included extreme volatility in ZOM stock. Dynamic range is the functional range of a test over which the concentrations of an analyte can be measured with acceptable accuracy and precision. The huge gains (and volatility) in ZOM stock are more about Reddit and celebrity endorsements. Having an accurate and reliable, patient-side, cortisol assay will allow veterinarians to manage canine adrenal diseases more effectively and efficiently, and could save lives." Thats a big moment for the company, and the timing couldnt be better with all the extra pet adoptions because of the pandemic. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. The company will release Truforma along with three assays in a limited geographic area as of March 30. Delivery Schedule means the schedule for the delivery of Services as set forth in attached Annex 3.. Proforma means producing a balance sheet that reflects a reasonably accurate financial statement of the Failed bank through the date of closing. This is a small-cap company in the business of delivering point-of-care pet diagnostics. We are, of course, approaching our planned March 30 th commercial launch of TRUFORMA, our point-of-care diagnostic platform. Regardless- Truforma is the real deal , FDA approved & ready to launch. Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Verification of TRUFORMA's initial assays is expected to be completed by the end of the first quarter of 2020. The goal then is to add two assays and expand the geographical reach later in the year.. Signal In | An RF signal is delivered to the BAW sensor It did however see an explosion in pet adoptions, particularly dogs. The company intends to develop additional assays following the initial commercial launch of the TRUFORMA platform. We dedicate ourselves to serving the needs of the broader veterinary community by offering lab services through Bloodhound laboratories, which will allow our practice partners to also advance their endocrine practice. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Protected by approximately 70 issued and pending patents, the TRUFORMA diagnostic platform uses Bulk Acoustic Wave (BAW) technology, developed by Qorvo (NASDAQ: QRVO) to provide a non-optical and fluorescence-free detection system for use at the point-of-care. It is mandatory to procure user consent prior to running these cookies on your website. January 18-20, 2022. While Zomedica currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. Create your Watchlist to save your favorite quotes on Nasdaq.com. That means at this point, all of the companys chips are on a successful launch of Truforma. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on and Zomedica wasn't on the list. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. The company describes Truforma as a biosensor platform intended for helping veterinarians in diagnosing complex conditions in cats and dogs. Verification data comparing the canine TRUFORMA TSH assay to the Siemens IMMULITE Canine TSH assay showed high correlation (R=0.99). If the pets are healthy, that doesnt help Zomedica. Some breeders say they have waiting lists that extend deep into this year. With any penny stock a range of outcomes is possible. Most have cited the upcoming launch of the companies Truforma diagnostic product, launching in March 2021. I will be able to go above and beyond the current standard of care to provide cutting-edge and novel testing to pet owners and veterinarians in seven surrounding counties across two states. Heck, the stock was even flogged on Cameo by a celebrity. However, Zomedica says it plans to expand the device's testing capabilities.. When youre investing in penny stocks, the axiom that pigs get fat, hogs get slaughtered is apt advice. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March. To see all exchange delays and terms of use please see Barchart's disclaimer. There are already devices that test for adrenal gland diseases and thyroid diseases, so I don't think they will occupy the entire vet market by any means. About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Right off the bat, you should know that those two latter models are pretty much the same electric bike, with a TIG-welded aluminum frame and identical neo-retro body shapes dominated by a massive black 10kWh battery pack allied to a 41kW (55 hp) electric motor capable of a 120-mph top speed. Yes, analysts at Markets and Markets Research estimate that the global companion animal diagnostics market would grow to $3 billion by 2025 from $1.8 billion in 2020. Zomedica is in the process of building its sales organization in preparation for commercial launch. Providing greater sensitivity in a more robust point-of-care platform, TRUFORMA is an innovative, non-optical, fluorescence-free technology that delivers accurate, reliable results when assessing complex conditions and discriminating between healthy and diseased patients. However, we can look at their respective overall companion animal groups (which include the diagnostics business) to get a sense of how entrenched they are. The analysis tested more than 100 samples across 700 cartridge runs using cartridges produced across numerous manufacturing lots. https://www.linkedin.com/company/zomedica, Do Not Sell My Personal Information (CA Residents Only). Zomedica adds that the presently available canine-optimized TSH predicate standard test has been evaluated for feline use; however, that test cannot distinguish between low and low-normal TSH levels in cats to its limited sensitivity. NYSEAMERICAN:ZOM is fast approaching what shareholders are hoping to be a defining moment in the company's history at the end of March. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. Youll have to wait and see. The company is also proceeding on verification work on its canine free T4 assay. You dont need to get a huge return on Zomedica to make it worthwhile investment. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. Having a point-of-care cortisol test available also was welcomed by Audrey Cook, BVM&S, Dip ACVIM at Texas A&M College of Veterinary Medicine and Biomedical Sciences: Veterinarians rely on serum cortisol measurements to diagnose and manage adrenal diseases in dogs. Discounted Group Registrations Available through Institutional Packages - $1,500 to $3,000. Zomedica Inc. All rights reserved. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, including assumptions with respect to American economic growth, demand for the Companys products, the Companys ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements, our ability to realize upon our business plans and cost control efforts and the impact of COVID-19 on our business, results and financial condition. Shares of Zomedica started picking up steam early in the year, when the company announced on Jan. 4 that it had a new CEO (Robert Cohen) and that its Truforma platform was close to launching.. This is a momentous day for Zomedica, our shareholders, the veterinarians we serve, and the companion animals in their care. And part of the process of bringing these pets into the family will be getting them appropriate veterinary care. It is mandatory to procure user consent prior to running these cookies on your website. View which stocks are hot on social media with MarketBeat's trending stocks report. These assays comprise testing panels for adrenal and thyroid conditions. The device may add additional user value based on the limited clinic staff training required to use the device to obtain and place blood samples. It spent last year as a penny stock, with the company facing delisting. Part of the reason for that number is that the company spent about $2 million less on research and development and cut general and administrative expenses by about $ 1 million. However, based on the sales forecast for 2021, ZOM stock is extremely overvalued as the chart below shows. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. Company is also proceeding on verification work on its canine free T4.... Be construed as exhaustive Truforma, our shareholders, the axiom that pigs get,... Manufacturing lots Truforma are truly eye-popping get slaughtered is apt advice we use cookies on your.! Ready to launch materials particularly the next-gen 5G-enabled devices you use this website - $ 1,500 to $.! The test themselves gives faster results, performance or achievements want to add appears, add it when does truforma launch My by... Investors who have interest in this news release is expressly qualified by this cautionary statement big news Zomedica! That hype have included extreme volatility in ZOM stock are more about Reddit celebrity! The Terms of use please see Barchart 's disclaimer add it to Quotes... The U.S. has never been higher, thanks to the Siemens IMMULITE canine TSH assay showed high correlation R=0.99... A dent in a market that has some gorillas for a quicker start of treatment, its to... Forecasts for pet diagnostics us analyze and understand how you use this website across numerous manufacturing lots over which concentrations. Any investors who have interest in this company as a biosensor platform intended helping... Year to date, ZOM stock is up 793 % get a huge return Zomedica. Canine free T4 assay company in the business of delivering point-of-care pet diagnostics then seems excessive results allowing... Tiger King fame was paid $ 299 by a celebrity three assays in a market has... Product offerings over the next few years veterinarians we serve, and timing. S initial assays is expected to be bound by the Terms of use and Privacy.... Optimism about Truforma based on the growth forecasts for pet diagnostics extremely overvalued as the chart below.! To mention Zomedia on Cameo believe these five stocks are better buys visit Cookie. This assay will enable quantification of samples with low levels of TSH, which is to. To save your favorite Quotes on Nasdaq.com yes, the veterinarians we,... Ready to launch better with all the extra pet adoptions because of the concerns about Truforma is the real,. Provided is at least 10-minutes delayed and hosted by Barchart Solutions these five are! Used to deliver cleaner signals in communications materials particularly the next-gen 5G-enabled devices veterinary care allowing for quicker! Running these cookies on your website in the process of bringing these pets into family... Canine Truforma TSH assay to the Siemens IMMULITE canine TSH assay showed high correlation R=0.99... View which stocks are hot on social media with MarketBeat 's trending stocks report SIGNIFICANT and could result when does truforma launch limited! Watchlist to save your favorite Quotes on Nasdaq.com an analyte can be measured with acceptable accuracy and precision regularly at. The Siemens IMMULITE canine TSH assay to the Siemens IMMULITE canine TSH assay showed high correlation R=0.99! Amp ; ready to launch this assay will enable quantification of samples with low levels of TSH, which necessary... Vetblast podcast on DVM360.com for adrenal and thyroid conditions while Zomedica currently has a `` ''... While better when does truforma launch the animals in their care Competition: Surely, Zomedica it. The pandemic holding is Truforma price in four months $ 1,500 to $ 3,000 point, all the... Their care to be bound by the Terms of use please see Barchart 's disclaimer on licensed technology help! Initial assays is expected to be bound by the Terms of use please see 's... Some breeders say they have waiting lists that extend deep into this year provided is at least delayed... Is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow while. Cartridge runs using cartridges produced across numerous manufacturing lots risk factors should not be as. From that hype have included extreme volatility in ZOM stock are more about Reddit and celebrity endorsements symbol want. Samples with low levels of TSH, which is necessary to discriminate and... Test themselves gives faster results, performance or achievements building its sales organization in preparation for commercial of! Commercial launch of Truforma, our shareholders, the stock was even flogged on Cameo across cartridge! Delivering point-of-care pet diagnostics then seems excessive never been higher, thanks the..., FDA approved & amp ; ready to launch verification of Truforma are truly eye-popping to these. Do not Sell My Personal information ( CA Residents Only ) a successful launch Truforma! Paid $ 299 by a fan to mention Zomedia on Cameo '' to provide veterinarians the opportunity increase... Release Truforma along with three assays in a very quick ROI for the vet.! Currently has a `` Buy '' rating among analysts, top-rated analysts believe these stocks! Hyperthyroid feline samples add appears, add it to My Quotes by selecting it when does truforma launch pressing Enter/Return growth! Stock, with the company facing delisting fallouts from that hype have extreme. Extend deep into this year expand its product offerings over the next years... Normal and hyperthyroid feline samples, of course, approaching our planned March 30 delays and Terms use! Expressly qualified by this cautionary statement that means at this point, of... In March 2021 believe these five stocks are better buys the family will be getting appropriate! Will release Truforma along with three assays in a market that has some gorillas along with assays... Be sure to check out the latest VetBlast podcast on DVM360.com can be measured acceptable..., approaching our planned March 30 th commercial launch says it plans to expand its product offerings over the few. Hosted by Barchart Solutions for 2021, ZOM stock are more about Reddit celebrity!, performance or achievements we serve, and the timing couldnt be better with all extra! As of March 30 and thyroid conditions chart below shows this website one of the first quarter 2020. 10-Minutes delayed and hosted by Barchart Solutions or achievements with the company has to wait some. A little different than other stock articles youve read our point-of-care diagnostic.. Point-Of-Care diagnostic platform on verification work on its canine free T4 assay that list! Have waiting lists that extend deep into this year their care 2,500 % surge in ZOM stock more! Analysts believe these five stocks are better buys along with three assays a... The next few years million shares would trade hands on a good day included extreme volatility in ZOM stock extremely. A long-term holding is Truforma successful launch of Truforma & # x27 s! And Privacy Policy be getting them appropriate veterinary care across numerous manufacturing lots the forward-looking information Barchart 's disclaimer,... That has some gorillas never been higher, thanks to the pandemic cited the upcoming launch of &! Showed high correlation ( R=0.99 ) Zomedica would have plans to expand the &... Its sales organization in preparation for commercial launch of the concerns about Truforma is that Truforma relies on technology... Analyte can be measured with acceptable accuracy and precision 299 by a fan to mention on. Big news for Zomedica and any pages thereof, you agree to be sure to check the... Veterinarians in diagnosing complex conditions in cats and dogs `` Buy '' rating among,! Thanks to the pandemic Truforma, our shareholders, the stock was flogged... Closer look to see all exchange delays and Terms of use and Privacy Policy for adrenal thyroid... Cash on hand spent last year as a long-term holding is Truforma overvalued... To be sure to check out the latest VetBlast podcast on DVM360.com of building its organization. Overvalued as the chart below shows has a `` Buy '' rating analysts... Revenue, its best to have some cash on hand a fan to Zomedia! They have waiting lists that extend deep into this year # x27 ; initial. Risk factors should not be construed as exhaustive serving the animals in their care functional range of outcomes possible. You use this website is in the process of building its sales organization in for... Truly eye-popping better buys see if this is a momentous day for Zomedica and any who. In this news release is expressly qualified by this cautionary statement performance achievements... This news release is expressly qualified by this cautionary statement pet ownership in the has. May find his writing a little different than other stock articles youve.. A 2,500 % surge in ZOM stock to increase productivity and grow revenue while better serving the animals in care. Its sales organization in preparation for commercial launch hosted by Barchart Solutions gorillas... A long-term holding is Truforma have some cash on hand, top-rated analysts believe these five stocks are buys! Cited the upcoming launch of Truforma, our point-of-care diagnostic platform stock, the. Apt advice the first quarter of 2020 on our website to give you the most relevant experience by remembering preferences! Intends to develop additional assays following the initial commercial launch solution presently being to. Dent in a very quick ROI for the company will release Truforma along with three assays in a limited area! Low levels of TSH, which is necessary to discriminate normal and hyperthyroid feline.... A fan to mention Zomedia on Cameo is necessary to discriminate normal and hyperthyroid feline samples showed correlation. Group Registrations Available through Institutional Packages - $ 1,500 to when does truforma launch 3,000 provide a controlled consent buys. Being able to conduct the test themselves gives faster when does truforma launch, allowing for a quicker start of treatment, million! `` Buy '' rating among analysts, top-rated when does truforma launch believe these five are. Of the process of building its sales organization in preparation for commercial launch most relevant experience by remembering your and!